Abstract: PO1776
Glomerular Proteomics Reveal Shared Pathways Across Several Disease
Session Information
- Glomerular Diseases: Lupus and Membranous
October 22, 2020 | Location: On-Demand
Abstract Time: 10:00 AM - 12:00 PM
Category: Glomerular Diseases
- 1202 Glomerular Diseases: Immunology and Inflammation
Authors
- Almaani, Salem, The Ohio State University, Columbus, Ohio, United States
- Ayoub, Isabelle, The Ohio State University, Columbus, Ohio, United States
- Shapiro, John P., The Ohio State University, Columbus, Ohio, United States
- Madhavan, Sethu M., The Ohio State University, Columbus, Ohio, United States
- Satoskar, Anjali A., The Ohio State University, Columbus, Ohio, United States
- Merchant, Michael, University of Louisville, Louisville, Kentucky, United States
- Klein, Jon B., University of Louisville, Louisville, Kentucky, United States
- Rovin, Brad H., The Ohio State University, Columbus, Ohio, United States
- Parikh, Samir V., The Ohio State University, Columbus, Ohio, United States
Background
Glomerular diseases are caused by a variety of immunologic and metabolic disturbances. While there is considerable disease heterogeneity, morphologic patterns of injury are limited and clinical phenotypes are similar across diseases. This suggests that mechanisms of inflammation and the glomerular response to injury is similar across disease states. Characterizing these mechanisms may provide insights into the common pathways of glomerular injury and lead to new insights in pathogenesis and treatment. As a first step, we used an agnostic proteomics approach to identify common regulated pathways across a variety of glomerular disorders.
Methods
Kidney biopsies from 36 patients across several glomerular diseases and 21 controls (transplant donor biopsies) were used. Glomeruli were isolated using laser-capture microdissection, processed, and submitted for LC-MS/MS. Peptides were analyzed for spectral count quantitation. Spectral counts of each disease were compared to control samples that were analyzed in the same batch. Only peptides with a spectral count coefficient of variation <1 were included in expression ratio calculations. Disease-to-control expression ratios >2 or <0.5 were used for pathway analysis using Reactome. The top 10 pathways were grouped into domains and are depicted in figure 1.
Results
Pathways involved in complement regulation and activation, fibrin clot formation, and platelet aggregation were upregulated in most disease categories. On the other hand, pathways of carbohydrate, protein, amino acid metabolism, and cell cycle pathways were downregulated in most disease categories.
Conclusion
Proteomic analysis of a heterogeneous population of glomerular diseases identified several shared dysregulated pathways that may reflect common final pathways associated with glomerular injury. These pathways reflect important immunologic and metabolic changes that have the potential to be leveraged therapeutically across a variety of glomerular diseases in a manner similar to RAAS blockade.